Results 31 to 40 of about 26,115 (197)

Use of cognitive enhancers: Methylphenidate and analogs [PDF]

, 2019
OBJECTIVE: In the last decades, several cognitive-enhancing drugs have been sold onto the drug market. Methylphenidate and analogs represent a sub-class of these new psychoactive substances (NPS).
Giorgetti, R., Ricci, G., Varì, M. R., PIRANI, FILIPPO, Carlier, J., Busardò, F. P.   +5 more
core   +3 more sources

Methylphenidate use among students living in junior on-campus residences of the University of the Free State

South African Family Practice, 2017
Background: The use of methylphenidate as cognitive enhancer is a growing trend among students at tertiary institutions globally. This study aimed to determine the prevalence of methylphenidate use and co-use with alcohol among on-campus residence ...
P M Van Zyl, G Joubert, L Fechter, j Griesel, M Nel, A Honiball, L Serfontein, M Diedericks   +7 more
doaj   +1 more source

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder

Journal of Central Nervous System Disease, 2010
Objective To review the literature on the safety and efficacy of methylphenidate, OROS-methylphenidate, methylphenidate ER, and dexmethylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).
Michael A. Sopko, Harjeet Caberwal, Benjamin Chavez   +2 more
doaj   +1 more source

Non-medical use of methylphenidate among medical students of the University of the Free State

South African Journal of Psychiatry, 2017
Background: Faced with demanding training programmes, medical students may be more prone to use methylphenidate for non-medical purposes in order to improve concentration, alertness and academic performance.
Roshini Jain, Ch Chiech Chang, Mpho Koto, Alden Geldenhuys, Richard Nichol, Gina Joubert   +5 more
doaj   +1 more source

Increased performance uncertainty in children with ADHD? - Elevated post-imperative negative variation (PINV) over the ventrolateral prefrontal cortex [PDF]

, 2011
Background: We aimed to investigate the influences of attention deficit/hyperactivity disorder (ADHD) on response evaluation, as reflected by the postimperative negative variation (PINV), a slow event-related potential.
Werner, Janina, Resch, Franz, Weisbrod Matthias, Stephan Bender, Rößner, Veit, Matthias Weisbrod, Veit Roessner, Werner Janina, Bender Stephan, Roessner, Veit, Franz Resch, Roessner Veit, Bender, Stephan, Resch Franz, Weisbrod, Matthias, Janina Werner   +15 more
core   +1 more source

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder

Journal of Advanced Pharmaceutical Technology & Research, 2016
Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder among preschool children but the number of controlled clinical trials regarding psychopharmacological treatment in this age group is limited.
Parvin Safavi, Ali Hasanpour Dehkordi, Nasim Ghasemi   +2 more
doaj   +1 more source

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD

Pharmaceuticals, 2023
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders. It was once thought to be a disorder affecting only children, but in those undiagnosed in childhood, symptoms do not disappear with age.
Rafał Bieś, Joanna Fojcik, Anna Warchala, Beata Trędzbor, Krzysztof Krysta, Katarzyna Piekarska-Bugiel, Marek Krzystanek   +6 more
doaj   +1 more source

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial [PDF]

, 2014
David R Coghill,1 Tobias Banaschewski,2 Michel Lecendreux,3 César Soutullo,4 Alessandro Zuddas,5 Ben Adeyi,6 Shaw Sorooshian7 1Division of Neuroscience, University of Dundee, Dundee, UK; 2Child and Adolescent Psychiatry and Psychotherapy, Central
Banaschewski T, Sorooshian S, Sorooshian, Shaw, Coghill DR, Lecendreux M, Coghill, DR, Soutullo, C, Soutullo, César, Banaschewski, Tobias, SOROOSHIAN S., Banaschewski, T, Adeyi, B, Coghill, David R., Zuddas, Alessandro, Adeyi B, Adeyi, Ben, Sorooshian, S, Zuddas A, Zuddas, A, Lecendreux, Michel, Lecendreux, M, Soutullo C   +21 more
core   +1 more source

Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017

Journal of the Formosan Medical Association, 2023
This study documented the prescribing patterns of methylphenidate and atomoxetine among patients aged 3 to 18 in Taiwan diagnosed with attention deficit hyperactivity disorder (ADHD) between 2004 and 2017. Initial treatment for ADHD, the time between the
Heng-Ching Liao, Fang-Ju Lin, Chien-Ning Hsu, Susan Shur-Fen Gau, Chi-Chuan Wang   +4 more
doaj   +1 more source

Sustained Release Methylphenidate [PDF]

, 2000
As sustained methylphenidate becomes available in the United Kingdom, there is likely to be considerable demand related to the difficulties that frequently arise with standard methylphenidate due to the need for midday doses at school, as well as the ...
Eric Taylor, Tamsin Ford, Jody Warner Rogers   +2 more
core   +1 more source